AI-generated analysis. Always verify with the original filing.
IN8bio, Inc. issued a press release on March 12, 2026, announcing its financial results for the fourth quarter. The filing includes Exhibit 99.1, the press release, under Item 9.01.
Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On March 12, 2026, IN8bio, Inc. (the “Company”) issued a press release announcing its financial results for fourt
Financial Statements and Exhibits. d) Exhibits. Exhibit No. Description 99.1 Press Release, dated March 12, 2026. 104 Cover Page Interactive Data File (embedded